The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Splicing biomarkers of disease severity in myotonic dystrophy
Open accessAbstract
Objective: To develop RNA splicing biomarkers of disease severity and therapeutic response in myotonic dystrophy type 1 (DM1) and type 2 (DM2). Methods: In a discovery cohort, we used microarrays to perform global analysis of alternative splicing in DM1 and DM2. The newly identified splicing changes were combined with previous data to create a panel of 50 putative splicing defects. In a validation cohort of 50 DM1 subjects, we measured the strength of ankle dorsiflexion (ADF) and then obtained a needle biopsy of tibialis anterior (TA) to analyze splice events in muscle RNA. The specificity of DM‐associated splicing defects was assessed in disease controls. The CTG expansion size in muscle tissue was determined by Southern blot. The reversibility of splicing defects was assessed in transgenic mice by using antisense oligonucleotides to reduce levels of toxic RNA. Results: Forty‐two splicing defects were confirmed in TA muscle in the validation cohort. Among these, 20 events showed graded changes that correlated with ADF weakness. Five other splice events were strongly affected in DM1 subjects with normal ADF strength. Comparison to disease controls and mouse models indicated that splicing changes were DM‐specific, mainly attributable to MBNL1 sequestration, and reversible in mice by targeted knockdown of toxic RNA. Splicing defects and weakness were not correlated with CTG expansion size in muscle tissue. Interpretation: Alternative splicing changes in skeletal muscle may serve as biomarkers of disease severity and therapeutic response in myotonic dystrophy. Ann Neurol 2013;74:862–872
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kress, W., Naylor, S. L., Day, J. W., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,231
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy
Philips, A. V., Timchenko, L. T., & Cooper, T. A. (1998) · Science · doi:10.1126/science.280.5364.737 · Cited by 818
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
A Muscleblind Knockout Model for Myotonic Dystrophy
Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743
Self-citationMyotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat
Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M., & Thornton, C. A. (2000) · Science · doi:10.1126/science.289.5485.1769 · Cited by 737
Self-citationMankodi, A., Takahashi, M. P., Jiang, H., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Self-citationCharlet-B., N., Savkur, R. S., Singh, G., Philips, A. V., Grice, E. A., & Cooper, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00572-5 · Cited by 619
Myosin isoforms in mammalian skeletal muscle
Schiaffino, S., & Reggiani, C. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.77.2.493 · Cited by 539
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy
Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S., & Thornton, C. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl132 · Cited by 510 · cited 17×
“We also compared 5 splice events regulated by MBNL1 but not CELF1 (CLCN1, TTN, MBNL1 exon 7, MBNL2 exon 7, and PDLIM3 exon 5).(18,26,34) CLCN1 splicing was affected in nearly all subjects, whereas MBNL1 and MBNL2 mis-splicing were mainly present in the severely affected subjects (see Supplementary Fig 9B).”
BackgroundMethodResultInfluentialSelf-citationA postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
Kalsotra, A., Xiao, X., Ward, A. J., Castle, J. C., Johnson, J. M., Burge, C. B., & Cooper, T. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809045105 · Cited by 508
Targeting nuclear RNA for in vivo correction of myotonic dystrophy
Wheeler, T. M., Leger, A. J., Pandey, S. K., MacLeod, A. R., Nakamori, M., Cheng, S. H., Wentworth, B. M., Bennett, C. F., & Thornton, C. A. (2012) · Nature · doi:10.1038/nature11362 · Cited by 502
Self-citationThe myotonic dystrophies: molecular, clinical, and therapeutic challenges
Udd, B., & Krahe, R. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70204-1 · Cited by 491
Amphiphysin 2 (Bin1) and T-Tubule Biogenesis in Muscle
Lee, E., Marcucci, M., Daniell, L., Pypaert, M., Weisz, O. A., Ochoa, G.-C., Farsad, K., Wenk, M. R., & De Camilli, P. (2002) · Science · doi:10.1126/science.1071362 · Cited by 463
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2
Mankodi, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2165 · Cited by 458
Kuyumcu-Martinez, N. M., Wang, G.-S., & Cooper, T. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.027 · Cited by 445
Repeat instability as the basis for human diseases and as a potential target for therapy
López Castel, A., Cleary, J. D., & Pearson, C. E. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2854 · Cited by 429
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Wheeler, T. M., Sobczak, K., Lueck, J. D., Osborne, R. J., Lin, X., Dirksen, R. T., & Thornton, C. A. (2009) · Science · doi:10.1126/science.1173110 · Cited by 387
Self-citationGardina, P. J., Clark, T. A., Shimada, B., Staples, M. K., Yang, Q., Veitch, J., Schweitzer, A., Awad, T., Sugnet, C., Dee, S., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-325 · Cited by 352
Fugier, C., Klein, A. F., Hammer, C., Vassilopoulos, S., Ivarsson, Y., Toussaint, A., Tosch, V., Vignaud, A., Ferry, A., Messaddeq, N., et al. (2011) · Nature Medicine · doi:10.1038/nm.2374 · Cited by 335
Du, H., Cline, M. S., Osborne, R. J., Tuttle, D. L., Clark, T. A., Donohue, J. P., Hall, M. P., Shiue, L., Swanson, M. S., Thornton, C. A., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1720 · Cited by 332
Self-citationMyotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes
Thornton, C. A., Johnson, K., & Moxley, R. T. (1994) · Annals of Neurology · doi:10.1002/ana.410350116 · Cited by 275
Self-citationKimura, T., Nakamori, M., Lueck, J. D., Pouliquin, P., Aoike, F., Fujimura, H., Dirksen, R. T., Takahashi, M. P., Dulhunty, A. F., & Sakoda, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi223 · Cited by 275
Self-citationPentamidine reverses the splicing defects associated with myotonic dystrophy
Warf, M. B., Nakamori, M., Matthys, C. M., Thornton, C. A., & Berglund, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903234106 · Cited by 263
Self-citationTriplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Mulders, S. A. M., van den Broek, W. J. A. A., Wheeler, T. M., Croes, H. J. E., van Kuik-Romeijn, P., de Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905780106 · Cited by 257
Self-citationWheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T., & Thornton, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33355 · Cited by 256
Self-citationMuscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs
Yuan, Y., Compton, S. A., Sobczak, K., Stenberg, M. G., Thornton, C. A., Griffith, J. D., & Swanson, M. S. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm601 · Cited by 212
Self-citationSomatic instability of CTG repeat in myotonic dystrophy
Ashizawa, T., Dubel, J. R., & Harati, Y. (1993) · Neurology · doi:10.1212/wnl.43.12.2674 · Cited by 188
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1
Ward, A. J., Rimer, M., Killian, J. M., Dowling, J. J., & Cooper, T. A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq277 · Cited by 166
Braida, C., Stefanatos, R. K. A., Adam, B., Mahajan, N., Smeets, H. J. M., Niel, F., Goizet, C., Arveiler, B., Koenig, M., Lagier‐Tourenne, C., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq015 · Cited by 165
López, A., Nakamori, M., Tomé, S., Chitayat, D. A., Gourdon, G., Thornton, C. A., & Pearson, C. E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq427 · Cited by 162
Self-citationParkesh, R., Childs‐Disney, J. L., Nakamori, M., Kumar, A., Wang, E. T., Wang, T., Hoskins, J. W., Tran, T. A., Housman, D. E., Thornton, C. A., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210088v · Cited by 144
Self-citationEdwards, R. H. T., Young, A., & Wiles, C. M. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001313020504 · Cited by 137
(1997) · Neurology · doi:10.1212/wnl.48.1.38 · Cited by 131
Zatz, M., Passos-Bueno, M., Cerqueira, A., Marie, S. K., Vainzof, M., & Pavanello, R. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.3.401 · Cited by 86
Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
François, V., Klein, A. F., Beley, C., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1958 · Cited by 79
Alternative Splicing in Disease
Orengo, J. P., & Cooper, T. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-77374-2_13 · Cited by 73
Alternative splicing dysregulation secondary to skeletal muscle regeneration
Orengo, J. P., Ward, A. J., & Cooper, T. A. (2010) · Annals of Neurology · doi:10.1002/ana.22278 · Cited by 63
Hilbert, J. E., Kissel, J. T., Luebbe, E. A., Martens, W. B., McDermott, M., Sanders, D. B., Tawil, R., Thornton, C. A., & Moxley, R. T. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.11.016 · Cited by 61
Self-citationRibonuclear foci at the neuromuscular junction in myotonic dystrophy type 1
Wheeler, T. M., Krym, M., & Thornton, C. A. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.12.015 · Cited by 58
Self-citationMoxley, R. T., Moxley, R. T., Logigian, E. L., et al. (2007) · Muscle & Nerve · doi:10.1002/mus.20822 · Cited by 52
Self-citationAltered mRNA splicing of dystrophin in type 1 myotonic dystrophy
Nakamori, M., Kimura, T., Fujimura, H., et al. (2007) · Muscle & Nerve · doi:10.1002/mus.20809 · Cited by 49
Self-citationAberrantly spliced α-dystrobrevin alters α-syntrophin binding in myotonic dystrophy type 1
Nakamori, M., Kimura, T., Kubota, T., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000302174.08951.cf · Cited by 45
Self-citationZhou, Y., Jiang, D., Thomason, D. B., & Jarrett, H. W. (2007) · Biochemistry · doi:10.1021/bi701384k · Cited by 41
Panaite, P., Gantelet, E., Kraftsik, R., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318180ec64 · Cited by 37
Rojas, J. M., Subleski, M., Coque, J. J., Guerrero, C., Sáez, R., Li, B.-Q., López, E., Zarich, N., Aroca, P., Kamata, T., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202483 · Cited by 14
Cited by
Lagier-Tourenne, C., Baughn, M., Rigo, F., Sun, S., Liu, P., Li, H.-R., Jiang, J., Watt, A. T., Chun, S., Katz, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318835110 · Cited by 561
Thornton, C. A. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.04.011 · Cited by 377
Self-citationFeingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000526 · Cited by 306
Batra, R., Charizanis, K., Manchanda, M., Mohan, A., Li, M., Finn, D. J., Goodwin, M., Zhang, C., Sobczak, K., Thornton, C. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.027 · Cited by 292
Self-citation(2023) · doi:10.1038/s41467-023-38923-6 · Cited by 21
Metadata
- Authors
- Nakamori, M., Sobczak, K., Puwanant, A., Welle, S., Eichinger, K., Pandya, S., Dekdebrun, J., Heatwole, C. R., McDermott, M. P., Chen, T., Cline, M., Tawil, R., Osborne, R. J., Wheeler, T. M., Swanson, M. S., Moxley, R. T., & Thornton, C. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-12
- Volume
- 74
- Issue
- 6
- Pages
- 862-872
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2141427674
- Cited by
- 265
- References
- 47
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.